Jove
Visualize
Contact Us

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

Diabetes care·2001
Same author

Physical performance in persons with spinal cord injuries after discharge from rehabilitation.

Medicine and science in sports and exercise·1999
Same author

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

Diabetes care·1998
Same author

New oral agents for type II diabetes. Taking a more aggressive approach to therapy.

Postgraduate medicine·1995
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current trends in treating type 2 diabetes.

P A Hollander1

  • 1Ruth Collins Diabetes Center, Baylor University Medical Center, Dallas, TX 75246, USA. priscilh@baylordallas.edu

Postgraduate Medicine
|August 12, 2009
PubMed
Summary

Aggressive diabetes treatment is now recommended due to new insights into disease mechanisms and complications. Early diagnosis, intervention, and personalized management are key for better patient outcomes in diabetes care.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Research
  • Diabetology

Background:

  • Understanding diabetes mechanisms and complications has advanced significantly.
  • Microvascular and macrovascular complications necessitate more aggressive treatment strategies.
  • New therapeutic agents now enable more proactive diabetes management.

Purpose of the Study:

  • To outline current recommendations for aggressive diabetes management.
  • To highlight the importance of early intervention in prediabetic stages.
  • To emphasize individualized treatment regimens for diabetes patients.

Main Methods:

  • Review of recent advances in diabetes understanding.
  • Analysis of progress in therapeutic agent development.

Related Experiment Videos

  • Synthesis of current clinical recommendations for diabetes care.
  • Main Results:

    • Aggressive treatment approaches are now mandated by new scientific understanding.
    • Early management of impaired glucose tolerance is crucial.
    • Achieving target plasma glucose levels and personalized pharmacologic intervention are emphasized.

    Conclusions:

    • A proactive and individualized approach is essential for effective diabetes management.
    • Early diagnosis and treatment are critical for preventing complications.
    • The integration of new therapeutic agents supports more aggressive management strategies.